Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression.
Diodoro, M G
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression. [electronic resource] - International journal of cancer Nov 2000 - 329-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
0020-7136
Animals
Apoptosis
Endothelial Growth Factors--analysis
Female
Hyperplasia
Immunohistochemistry
Lymphokines--analysis
Male
Mice
Mice, Inbred BALB C
Mice, Transgenic
Neovascularization, Pathologic--pathology
Receptor, ErbB-2--physiology
Reverse Transcriptase Polymerase Chain Reaction
Salivary Gland Neoplasms--blood supply
Salivary Glands--pathology
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression. [electronic resource] - International journal of cancer Nov 2000 - 329-35 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
0020-7136
Animals
Apoptosis
Endothelial Growth Factors--analysis
Female
Hyperplasia
Immunohistochemistry
Lymphokines--analysis
Male
Mice
Mice, Inbred BALB C
Mice, Transgenic
Neovascularization, Pathologic--pathology
Receptor, ErbB-2--physiology
Reverse Transcriptase Polymerase Chain Reaction
Salivary Gland Neoplasms--blood supply
Salivary Glands--pathology
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors